SUPRIYA

Supriya Lifescience Limited

Supriya Lifescience Limited announced that its Board of Directors recommended a final dividend of Re. 1.00 per equity share (50%) for the financial year 2025-26, subject to shareholder approval at the upcoming Annual General Meeting. The company also informed shareholders about the applicable tax deduction at source (TDS) provisions on this dividend payout, effective from April 1, 2020. This communication details the varying TDS rates based on shareholder category and residential status, along with the required documentation for appropriate tax deduction.

SUPRIYA

SUPRIYA has announced the closure of its trading window for all insiders and designated persons, including their immediate relatives. This closure is effective from Wednesday, July 1, 2026. The trading window will reopen 48 hours after the company declares its unaudited financial results for the quarter ending June 30, 2026. This standard regulatory measure is taken in accordance with SEBI (Prohibition of Insider Trading) Regulations, indicating the upcoming release of the company's first-quarter financial performance.